Stock NAMS FRAZIER LIFESCIENCES ACQUISITION CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Frazier Lifesciences Acquisition Corporation

Equities

NAMS

NL00150012L7

End-of-day quote Nasdaq
Other stock markets
 23:00:00 14/05/2024 BST 		5-day change 1st Jan Change
19.81 EUR -3.37% Intraday chart for Frazier Lifesciences Acquisition Corporation -3.37% +77.35%
05-15 TD Cowen Starts NewAmsterdam Pharma With Buy Rating MT
05-09 Earnings Flash (NAMS) NEWAMSTERDAM PHARMA N.V. Reports Q1 Revenue $1.4M MT

Chart calendar Frazier Lifesciences Acquisition Corporation

d238f7731018985909bd8b02.t-Wl_aQZFAjVyjJcadlykIsXE1gGwT30DPuVeBf1Uwk.wov2uJZQdT-hlWM5AZAAwuFWJgxsq3WVZo_bEliha0ffnMKkkXdbMJCJRQ~ceb640935749c54168ec599a3277d38e

Upcoming events on Frazier Lifesciences Acquisition Corporation

05/06/2024 23:00 Annual General Meeting
04/08/2024 Q2 2024 Earnings Release (Projected)
10/11/2024 Q3 2024 Earnings Release (Projected)
27/03/2025 Q4 2024 Earnings Release (Projected)
06/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Frazier Lifesciences Acquisition Corporation

16/05/2024 14:00 R&D Day - Key Opinion Leader
14/05/2024 21:35 RBC Capital Markets Global Healthcare Conference
09/05/2024 13:00 Q1 2024 Earnings Release
07/04/2024 18:15 American College of Cardiology Scientific Meeting
11/03/2024 Jefferies Biotech on the Bay Summit
11/03/2024 20:00 Leerink Partners Global Biopharma Conference
04/03/2024 19:10 TD Cowen Health Care Conference
28/02/2024 13:00 Q4 2023 Earnings Release
07/02/2024 18:00 Guggenheim Healthcare Talks Biotechnology Conference
28/11/2023 20:30 Piper Sandler Healthcare Conference
16/11/2023 10:30 Jefferies London Healthcare Conference
13/11/2023 13:00 Q3 2023 Earnings Release
27/09/2023 18:50 Cantor Global Healthcare Conference
07/08/2023 12:15 Q2 2023 Earnings Release
07/06/2023 20:30 Jefferies Global Healthcare Conference
05/06/2023 13:00 Obicetrapib Phase 2b Clinical Trial Results Call
03/06/2023 17:00 National Lipid Association Scientific Meeting
08/05/2023 13:00 Q1 2023 Earnings Release
31/03/2023 13:00 Q4 2022 Earnings Release
08/03/2023 19:50 Cowen Health Care Conference

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million EUR		Released
Forecast
Spread 		0,00


97,5
98,2
-0.69%		13,0
14,2
-8.63%
8,45

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million EUR		Released
Forecast
Spread 		0,00


-6,96
7,11
-197.91%		-169
-172
2.01%
-184

Earnings before Tax (EBT)
Million EUR		Released
Forecast
Spread 		0,00


-78,1
7,00
-1215.03%		-163
-169
3.52%
-205

Net income
Million EUR		Released
Forecast
Spread 		-28,6


-78,1
7,00
-1215.03%		-163
-167
2.45%
-208

EPS
EUR		Released
Forecast
Spread 		-2,53


-0,96
0,08
-1300%		-1,98
-2,03
2.24%
-2,31

Announcement Date04/08/2231/03/2328/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million EUR		Released
Forecast
Spread
3,50


1,75

4,00
7,20
-44.44%
1,47


1,95

9,56



1,77

1,30
1,61
-18.88%
1,11


1,83


4,55


0,00


0,00

EBITDA
Million EUR		Released
Forecast
Spread









27,6


29,0

























EBIT
Million EUR		Released
Forecast
Spread
-25,5


-25,8





-34,2


-36,7





-48,0

-51,6
-46,7
-10.55%
-49,8


-45,1


-38,2


-39,6


-35,2

Earnings before Tax (EBT)
Million EUR		Released
Forecast
Spread



-39,3





-33,7


-37,5





-48,2

-93,8
-36,2
-158.85%
-46,3


-40,8


-35,2


-35,3


-30,8

Net income
Million EUR		Released
Forecast
Spread



-39,2





-33,7


-36,1

-75,1



-46,9

-93,8
-43,6
-115.03%
-47,2


-41,2


-35,9


-35,3


-30,8

EPS
EUR		Released
Forecast
Spread



-0,45





-0,41


-0,43

-0,92



-0,56

-0,99
-0,49
-101.98%
-0,53


-0,45


-0,39


-0,39


-0,34

Announcement Date--31/03/23--07/08/23-08/05/24-----

Upcoming sector events for Frazier Lifesciences Acquisition Corporation

23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for Frazier Lifesciences Acquisition Corporation

17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
15/05/2024 13:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
14/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
15/05/2024 21:01 CELCUITY INC.: Q1 2024 Earnings Release
14/05/2024 21:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 21:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 13:00 IMMUNOME, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. NAMS Stock
  4. Calendar Frazier Lifesciences Acquisition Corporation